Commentary on 'Late gastrointestinal complications of inferior vena cava filter placement: Case report and literature review'

摘要

Although most evidence-based guidelines recommend vena cava filter placement in patients with documented venous thromboembolism and a contraindication to anticoagulation, complication of anticoagulation, or recurrent venous thromboembolism despite therapeutic anticoagulation, expanded relative indications based on inconclusive evidence have included venous prophylaxis in high-risk surgical, medical, or trauma patients. Despite lack of evidence supporting filter use especially for venous thromboembolism prophylaxis, there has been a significant expansion in filter use in the United States over the past 30 years, which has raised concern within the Food and Drug Administration (FDA) resulting in a safety alert issued August 8, 2010 (http:// www.fda.gov/Safety/MedWatch/Safety Information/Safety AlertsforHumanMedicalProducts/ucm22 1707.htm).